Antisense modulation of serum amyloid A4 expression
US6455308B1 · kind B1 · utility
50Cited by
0References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 1, 2001 |
| Grant date | Sep 24, 2002 |
| Priority date | — |
| Expiry date | Aug 1, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of serum amyloid A4. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding serum amyloid A4. Methods of using these compounds for modulation of serum amyloid A4 expression and for treatment of diseases associated with expression of serum amyloid A4 are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.